基本信息
浏览量:2
职业迁徙
个人简介
“Dr. Finberg’s contributions as a physician-scientist include more than 300 publications, more than 40 years of continuous funding by the National Institutes of Health and numerous research grants from the Department of Defense, the Defense Advanced Research Projects Agency and multiple other agencies and companies,” Chancellor Collins said. “His work allows us to better understand viral receptors and entry to host responses, and most recently, methods to be responsive to pandemic influenza and now the SARS-CoV2 pandemic.
Finberg’s impact in shaping the Medical School’s response to the pandemic is particularly noteworthy. He has served as principal investigator on more than half a dozen clinical trials related to COVID-19. UMMS was one of the top enrolling sites in the world for the NIH’s remdesivir trial and was an important contributor to the Pfizer-BioNTech COVID-19 vaccine trial.
Finberg’s impact in shaping the Medical School’s response to the pandemic is particularly noteworthy. He has served as principal investigator on more than half a dozen clinical trials related to COVID-19. UMMS was one of the top enrolling sites in the world for the NIH’s remdesivir trial and was an important contributor to the Pfizer-BioNTech COVID-19 vaccine trial.
研究兴趣
论文共 177 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Wayne D. Harshbarger, Derrick Deming,Gordon J. Lockbaum,Nattapol Attatippaholkun,Maliwan Kamkaew,Shurong Hou,Mohan Somasundaran,Jennifer P. Wang,Robert W. Finberg,Quan Karen Zhu,Celia A. Schiffer,Wayne A. Marasco
Clinical Use of Anti-infective Agentspp.85-88, (2021)
Clinical Use of Anti-infective Agentspp.127-129, (2021)
Clinical Use of Anti-infective Agentspp.51-55, (2021)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn